Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
qTLyGtx3XJUpp9ps